Abstract / Description of output

Cellular senescence is a stress response involved in ageing and diverse disease processes including cancer, type-2 diabetes, osteoarthritis and viral infection. Despite growing interest in targeted elimination of senescent cells, only few senolytics are known due to the lack of well-characterized molecular targets. Here, we report the discovery of three senolytics using cost-effective machine learning algorithms trained solely on published data. We computationally screened various chemical libraries and validated the senolytic action of ginkgetin, periplocin and oleandrin in human cell lines under various modalities of senescence. The compounds have potency comparable to known senolytics, and we show that oleandrin has improved potency over its target as compared to best-in-class alternatives. Our approach led to several hundred-fold reduction in drug screening costs and demonstrates that artificial intelligence can take maximum advantage of small and heterogeneous drug screening data, paving the way for new open science approaches to early-stage drug discovery.
Original languageEnglish
JournalNature Communications
Early online date10 Jun 2023
Publication statusE-pub ahead of print - 10 Jun 2023

Keywords / Materials (for Non-textual outputs)

  • cellular senescence
  • machine learning
  • artificial intelligence
  • drug discovery
  • senolytics


Dive into the research topics of 'Discovery of senolytics using machine learning'. Together they form a unique fingerprint.

Cite this